iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q1 2025 vs. Q4 2024
How the institutions holding iTeos Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 137 | 1 | 132 | −4 |
| Shares | 34.1M | 60.4K | 37.0M | +2.89M (+8.5%) |
| Value | $262.2M | $463.9K | $220.7M | −$41.0M (−15.7%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 303,650 | $1.81M | 0.00% |
| Marshall Wace, LLP | 119,558 | $713.8K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 84,502 | $504.5K | 0.01% |
| Gsa Capital Partners LLP | 56,887 | $340.0K | 0.03% |
| Thrivent Financial for Lutherans | 49,145 | $293.0K | 0.00% |
| Engineers Gate Manager LP | 36,810 | $219.8K | 0.00% |
| K2 Principal Fund, L.P. | 29,178 | $174.2K | 0.03% |
| Virtus Investment Advisers, Inc. | 20,663 | $123.4K | 0.03% |
| Oxford Asset Management LLP | 19,889 | $118.7K | 0.05% |
| Tudor Investment Corp Et Al | 17,651 | $105.4K | 0.00% |
| Ieq Capital, LLC | 14,749 | $88.1K | 0.00% |
| Price T Rowe Associates Inc | 12,390 | $74.0K | 0.00% |
| Dynamic Technology Lab Private Ltd | 11,257 | $67.0K | 0.01% |
| Paloma Partners Management Co | 10,947 | $65.4K | 0.01% |
| UBS Asset Management Americas Inc | 2,154 | $12.9K | 0.00% |
| Versant Capital Management, Inc | 985 | $5.88K | 0.00% |
| Caitong International Asset Management Co., Ltd | 494 | $2.95K | 0.00% |
| Coldstream Capital Management Inc | 127 | $759 | 0.00% |
| Clear Street Markets LLC | 81 | $484 | 0.00% |
| Avion Wealth | 54 | $0 | 0.00% |
Sold out (24)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Boxer Capital Management, LLC | 946,915 | $7.27M |
| Raymond James Financial Inc | 150,967 | $1.16M |
| UBS Oconnor LLC | 125,589 | $964.5K |
| Empowered Funds, LLC | 69,072 | $530.5K |
| Squarepoint Ops LLC | 42,716 | $328.1K |
| Fox Run Management, L.L.C. | 37,838 | $290.6K |
| EntryPoint Capital, LLC | 29,850 | $229.2K |
| Balyasny Asset Management LLC | 28,350 | $217.7K |
| XTX Topco Ltd | 27,352 | $210.1K |
| HRT Financial LP | 24,964 | $191.0K |
| LMR Partners LLP | 22,972 | $176.4K |
| Virtu Financial LLC | 18,493 | $142.0K |
| Marquette Asset Management, LLC | 15,866 | $121.9K |
| Jain Global LLC | 13,800 | $106.0K |
| Virtus ETF Advisers LLC | 8,948 | $68.7K |
| Point72 (DIFC) Ltd | 8,794 | $67.5K |
| Simplex Trading, LLC | 6,070 | $46.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,574 | $19.8K |
| Leonteq Securities AG | 2,000 | $15.4K |
| Venturi Wealth Management, LLC | 1,237 | $9.50K |
| Skopos Labs, Inc. | 533 | $4.09K |
| Lindbrook Capital, LLC | 172 | $1.32K |
| Quadrant Capital Group LLC | 135 | $1.04K |
| Farther Finance Advisors, LLC | 19 | $146 |
Not filed for Q1 2025 yet (1)
Institutions that held iTeos Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 60,401 | $463.9K |